Skip to main content
. 2021 Jun 15;28(13):9086–9095. doi: 10.1245/s10434-021-10187-8

Fig. 1.

Fig. 1.

Enrollment, allocation, follow-up, and analysis of patients during the trial (the layout was adapted from the CONSORT 2010 statement).43ITT intention-to-treat group, mITT modified intention-to-treat group, PDAC pancreatic ductal adenocarcinoma